Xiao et al. discovered that IL-21 was highly expressed in CRSwNP groups, and suggested that IL-21 might be a therapeutic target for CRSsNP therapy [20]. The gene discussed is IL21; the disease is chronic rhinosinusitis without nasal polyps.